Kineta to Participate in H.C. Wainwright Virtual @Home Fireside Chat Series

February 7, 2024

https://www.globenewswire.com/news-release/2024/02/07/2825204/0/en/Kineta-to-Participate-in-H-C-Wainwright-Virtual-Home-Fireside-Chat-Series.html

SEATTLE, Feb. 07, 2024 (GLOBE NEWSWIRE) — Kineta, Inc. (Nasdaq:KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today that the company will participate in a virtual H.C. Wainwright @Home Fireside Chat Series on February 13, 2024. Shawn Iadonato, Ph.D., Chief Executive Officer of Kineta and Thierry Guillaudeux, Ph.D., Chief Scientific Officer of Kineta, will present an overview of recent clinical results of KVA12123, the company’s VISTA blocking immunotherapy in development for patients with advanced solid tumors.

Read more at globenewswire.com

Related news for (KA)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.